These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35272421)

  • 1. [Expert consensus on clinical diagnosis and treatment of portal hypertension with hepatocellular carcinoma (2022)].
    Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):310-320. PubMed ID: 35272421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension associated with hepatocellular carcinoma with cirrhosis.
    Cooney TG; Bauer DC; Knauer CM
    Am J Gastroenterol; 1980 Nov; 74(5):436-8. PubMed ID: 6263084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver surgery in cirrhosis and portal hypertension.
    Hackl C; Schlitt HJ; Renner P; Lang SA
    World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma.
    Piscaglia F; La Mura V; Ravaioli F
    Dig Liver Dis; 2023 Aug; 55(8):997-1000. PubMed ID: 37321913
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.
    Hernandez-Gea V; Turon F; Berzigotti A; Villanueva A
    World J Gastroenterol; 2013 Feb; 19(8):1193-9. PubMed ID: 23482437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on precise diagnosis and management of primary hepatocellular carcinoma in advanced stage (2023 version)].
    ; ;
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):910-920. PubMed ID: 37872086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis].
    Ganne-Carrié N; Mohand D; N'kontchou G; Grando-Lemaire V; Trinchet JC
    Gastroenterol Clin Biol; 2002 Jan; 26(1):73-7. PubMed ID: 11938045
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension.
    Duan YF; Li XD; Sun DL; Chen XM; An Y; Zhu F
    Am J Surg; 2015 Jul; 210(1):129-33. PubMed ID: 25457251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1250-1261. PubMed ID: 38253068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is portal hypertension a contraindication to hepatic resection?
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
    Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Portal hypertension and hepatocellular carcinoma in patients with alcoholic cirrhosis].
    Bataille C; Bercoff E; Lebrec D
    Acta Gastroenterol Belg; 1983; 46(1-2):18-20. PubMed ID: 6316702
    [No Abstract]   [Full Text] [Related]  

  • 18. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis. More doubts than clarity.
    Cucchetti A; Cescon M; Pinna AD
    Hepatology; 2015 Sep; 62(3):976-7. PubMed ID: 25598405
    [No Abstract]   [Full Text] [Related]  

  • 19. [Portal hypertension in localized hepatocellular carcinoma without cirrhosis].
    Streifler I; Dux S; Pitlik S
    Harefuah; 1982 Jan; 102(2):64-5. PubMed ID: 6284600
    [No Abstract]   [Full Text] [Related]  

  • 20. Portal hypertension and development of hepatocellular carcinoma: factors influencing significance in prognostic models.
    Christensen E
    J Hepatol; 2009 May; 50(5):848-9. PubMed ID: 19299028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.